Mucormycosis and COVID-19: a dual curse
JK Science
; 23(4):170-174, 2021.
Article
in English
| CAB Abstracts | ID: covidwho-1733420
ABSTRACT
Mucormycosis is a serious, but rare opportunistic, invasive and life-threatening fungal infection primarily caused by Rhizopus arrhizus with very high case fatality. Recently, its alarming rise in the number among COVID-19 patients mostly with uncontrolled diabetes and those who received excessive administration of steroids for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has raised interest among the scientific community to learn more about the said disease. The current review describes, its epidemiology, clinical presentation, risk factors, warning signs, diagnostic test and available preventive and treatment modalities for its effective management.
Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Pesticides and Drugs; Control [HH405]; Pharmacology [VV730]; human diseases; clinical aspects; risk factors; coronavirus disease 2019; viral diseases; pandemics; public health; mucormycosis; mycoses; mixed infections; immunocompromised hosts; opportunistic infections; patients; steroids; drug therapy; literature reviews; medical treatment; infections; Severe acute respiratory syndrome coronavirus 2; man; Clidemia hirta; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Clidemia; Melastomataceae; Myrtales; eudicots; angiosperms; Spermatophyta; plants; SARS-CoV-2; clinical picture; Koster's curse; soap bush; viral infections; multiple infections; chemotherapy
Search on Google
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
English
Journal:
JK Science
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS